STmiR: A Novel XGBoost-Based Framework for Spatially Resolved miRNA Activity Prediction in Cancer Transcriptomics

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

MicroRNAs (miRNAs) are critical regulators of gene expression in cancer biology; however, their spatial dynamics within tumor microenvironments (TME) remain underexplored owing to technical limitations in current spatial transcriptomics (ST) technologies. To address this gap, we present STmiR, a novel XGBoost-based framework for spatially resolved miRNA activity predictions. STmiR integrates bulk RNA-seq data (TCGA and CCLE) with spatial transcriptomics profiles to model nonlinear miRNA-mRNA interactions, achieving a high predictive accuracy (Spearman’s ρ > 0.8) across four major cancer types (breast, lung, ovarian, and prostate). Applied to 10X Visium ST datasets from nine cancers, STmiR identified six pan-cancer conserved miRNAs (e.g., hsa-miR-21, hsa-let-7a) consistently ranked in the top 40 across malignancies, and uncovered cell-type-specific regulatory networks in fibroblasts, B cells, and malignant cells. A breast cancer case study validated the utility of STmiR by linking miR-205 to androgen receptor (AR) signaling and miR-200b to epithelial-mesenchymal transition (EMT). By enabling the spatial mapping of miRNA activity, STmiR provides a transformative tool to dissect miRNA-mediated regulatory mechanisms in cancer progression and TME remodeling, with implications for biomarker discovery and precision oncology.

Highlights

  • First integration of XGBoost and spatial transcriptomics : STmiR pioneers a machine learning framework to predict miRNA activity in spatially heterogeneous tissues, overcoming limitations of linear correlation-based methods.

  • High accuracy and generalizability : Demonstrates robust performance (Spearman’s ρ > 0.8) across four cancer types validated by independent datasets.

  • Pan-cancer conserved miRNAs : Six miRNAs (e.g., hsa-miR-21 and hsa-let-7a) were shared across nine cancers, implicating their roles in core oncogenic pathways.

Key Contributions

  • Methodological innovation : Combines XGBoost’s nonlinear modeling with spatial transcriptomics to resolve miRNA activity in multicellular contexts.

  • Biological discovery : Uncovers the conserved and context-dependent roles of miRNAs in tumor progression and microenvironment crosstalk.

  • Translational impact : Provides a computational platform for identifying spatially regulated therapeutic targets in cancer.

Article activity feed